|
PTC124
Orally bioavailable 284 D-1,2,4-oxadiazole. Promotes readthrough of premature translation termination codons. Targets genetic disorders caused by nonsense mutations. Shows no concomitant effects on normal termination or mRNA decay.
Product Specification
Alternative Name: 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]-benzoic acid
Formula: C15H9FN2O3
MW: 284.2
CAS: 775304-57-9
Purity: ≥95%
Identity: Identity determined by MS, 1H- and 13C-NMR.
Appearance: White to off-white solid.
Solubility: Soluble in DMSO (5mg/ml).
Long Term Storage: -20°C
Handling: Protect from light. |